The Assessment of Molecular Breast Imaging (MBI) in Distinguishing Benign From Malignant Breast Disease
NCT01687790
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Breast Abnormalities
Interventions
DEVICE:
molecular breast imaging (Discovery)
Sponsor
University of Pittsburgh
Collaborators
[object Object]